$MGNX
MACROGENICS INC Stock $mgnx

$mgnx Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000112534519000098 Filed on July 31, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$18.74M	$10.59M	$18.83M
YoY Change	-9.89%	-43.76%	1030.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.80M	$12.10M	$11.10M
YoY Change	22.92%	9.01%	32.14%
% of Gross Profit
Research & Development	$44.85M	$51.44M	$52.01M
YoY Change	-2.96%	-1.1%	50.94%
% of Gross Profit
Depreciation & Amortization	$2.640M	$2.580M	$1.200M
YoY Change	-3.3%	115.0%	-40.0%
% of Gross Profit
Operating Expenses	$44.85M	$51.44M	$52.01M
YoY Change	-2.96%	-1.1%	50.94%
Operating Profit	-$37.94M	-$52.97M	-$44.31M
YoY Change	8.4%	19.53%	7.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$6.687M	$21.20M	$1.070M
YoY Change	-785.85%	1881.5%	103.81%
Pretax Income	-$44.60M	-$31.80M	-$43.20M
YoY Change	31.18%	-26.39%	6.14%
Income Tax
% Of Pretax Income
Net Earnings	-$44.63M	-$31.77M	-$43.24M
YoY Change	31.16%	-26.54%	6.37%
Net Earnings / Revenue	-238.15%	-299.89%	-229.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$912.1K	-$651.6K	-$1.024M
COMMON SHARES
Basic Shares Outstanding	48.89M shares	48.81M shares	42.15M shares
Diluted Shares Outstanding			42.15M shares

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$254.4M	$272.1M	$300.9M
YoY Change	-2.19%	-9.57%	23.47%
Cash & Equivalents	$156.6M	$180.3M	$238.7M
Short-Term Investments	$97.80M	$91.80M	$62.20M
Other Short-Term Assets	$12.30M	$9.800M	$3.400M
YoY Change	173.33%	188.24%	-24.44%
Inventory
Prepaid Expenses	$12.02M	$9.616M	$3.173M
Receivables	$9.503M	$5.613M	$17.84M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$276.2M	$287.6M	$322.1M
YoY Change	-3.29%	-10.7%	28.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.97M	$52.30M	$57.49M
YoY Change	-14.81%	-9.04%	148.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$25.25M	$43.79M	$7.346M
YoY Change	128.22%	496.04%	373.02%
Total Long-Term Assets	$75.22M	$96.08M	$64.84M
YoY Change	7.9%	48.19%	162.16%
TOTAL ASSETS
Total Short-Term Assets	$276.2M	$287.6M	$322.1M
Total Long-Term Assets	$75.22M	$96.08M	$64.84M
Total Assets	$351.5M	$383.7M	$386.9M
YoY Change	-1.1%	-0.83%	40.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.543M	$857.0K	$1.767M
YoY Change	157.91%	-51.5%	-15.37%
Accrued Expenses	$28.39M	$30.41M	$37.18M
YoY Change	-26.22%	-18.21%	66.59%
Deferred Revenue	$23.57M	$14.45M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$57.63M	$49.54M	$48.03M
YoY Change	20.01%	3.14%	60.68%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$38.60M	$39.70M	$26.80M
YoY Change	56.28%	48.13%	97.06%
Total Long-Term Liabilities	$38.60M	$39.70M	$26.80M
YoY Change	56.28%	48.13%	97.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$57.63M	$49.54M	$48.03M
Total Long-Term Liabilities	$38.60M	$39.70M	$26.80M
Total Liabilities	$96.25M	$89.23M	$74.86M
YoY Change	32.38%	19.2%	72.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$611.7M	-$567.1M	-$411.6M
YoY Change	37.26%	37.77%	10.94%
Common Stock	$866.9M	$861.5M	$723.6M
YoY Change	19.03%	19.05%	20.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$255.2M	$294.5M	$312.0M
YoY Change
Total Liabilities & Shareholders Equity	$351.5M	$383.7M	$386.9M
YoY Change	-1.1%	-0.83%	40.77%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$44.63M	-$31.77M	-$43.24M
YoY Change	31.16%	-26.54%	6.37%
Depreciation, Depletion And Amortization	$2.640M	$2.580M	$1.200M
YoY Change	-3.3%	115.0%	-40.0%
Cash From Operating Activities	-$17.39M	-$48.84M	-$57.73M
YoY Change	-52.97%	-15.4%	87.68%
INVESTING ACTIVITIES
Capital Expenditures	-$780.0K	-$580.0K	-$5.500M
YoY Change	-81.52%	-89.45%	-24.76%
Acquisitions
YoY Change
Other Investing Activities	-$5.590M	-$9.530M	-$2.310M
YoY Change	-232.78%	312.55%	-102.87%
Cash From Investing Activities	-$6.370M	-$10.12M	-$7.810M
YoY Change	63600.0%	29.58%	-110.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	40.00K	630.0K	103.8M
YoY Change	-71.43%	-99.39%	207.59%
NET CHANGE
Cash From Operating Activities	-17.39M	-48.84M	-57.73M
Cash From Investing Activities	-6.370M	-10.12M	-7.810M
Cash From Financing Activities	40.00K	630.0K	103.8M
Net Change In Cash	-23.72M	-58.33M	38.21M
YoY Change	-35.63%	-252.66%	-49.79%
FREE CASH FLOW
Cash From Operating Activities	-$17.39M	-$48.84M	-$57.73M
Capital Expenditures	-$780.0K	-$580.0K	-$5.500M
Free Cash Flow	-$16.61M	-$48.26M	-$52.23M
YoY Change	-49.3%	-7.6%	122.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001125345
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48893451	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42353301	shares
CY2019Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36112
	dei	Entity Registrant Name EntityRegistrantName	MACROGENICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1591613
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9704 Medical Center Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
	dei	City Area Code CityAreaCode	301
	dei	Local Phone Number LocalPhoneNumber	251-5172
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	MGNX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48893451	shares
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180316000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220128000	USD
CY2019Q2	us-gaap	Investments Investments	91820000	USD
CY2018Q4	us-gaap	Investments Investments	12735000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5613000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29583000	USD
CY2019Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9616000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6406000	USD
CY2019Q2	us-gaap	Other Assets OtherAssets	232000	USD
CY2018Q4	us-gaap	Other Assets OtherAssets	272000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	287597000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	269124000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52295000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56712000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43785000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6294000	USD
CY2019Q2	us-gaap	Assets Assets	383677000	USD
CY2018Q4	us-gaap	Assets Assets	332130000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	857000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4005000	USD
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30410000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33021000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14449000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	21721000	USD
CY2019Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	0	USD
CY2018Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	1018000	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3644000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	49535000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59940000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15413000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19001000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24278000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	10312000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	89226000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	89253000	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	489000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	424000	USD
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	860983000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	732727000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	34000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-567055000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-490271000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	294451000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	242877000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383677000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	332130000	USD
CY2019Q2	us-gaap	Revenues Revenues	10593000	USD
CY2018Q2	us-gaap	Revenues Revenues	18834000	USD
	us-gaap	Revenues Revenues	20255000	USD
	us-gaap	Revenues Revenues	23529000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51440000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52014000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	98500000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	97684000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12122000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11134000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22341000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20369000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	63562000	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	63148000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	120841000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	118053000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-52969000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-44314000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-100586000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-94524000	USD
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21202000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1070000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23802000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1744000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-31767000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-43244000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-76784000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-92780000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	34000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	40000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	37000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	79000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-31733000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-43204000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-76747000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-92701000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.65
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.63
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.35
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48845234	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42153813	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47234889	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39559599	shares
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	242877000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3750000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	118657000	USD
CY2019Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	347000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	3000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-45017000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	320617000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4933000	USD
CY2019Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	634000	USD
CY2019Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	34000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-31767000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	294451000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	299238000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-6479000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3386000	USD
CY2018Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	629000	USD
CY2018Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	38000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-49536000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	247276000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4209000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	103259000	USD
CY2018Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	496000	USD
CY2018Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	40000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-43244000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	312036000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-76784000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-92780000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5483000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2540000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8683000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	104384000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21091000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5511000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7595000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23971000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4194000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3209000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	22000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2598000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-684000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2663000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8215000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	0	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-298000	USD
	mgnx	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	231000	USD
	mgnx	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	0	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-10861000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3371000	USD
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-516000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-78838000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-89026000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	142305000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	86491000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	63955000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	118090000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2262000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20023000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-80612000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	11576000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	118657000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	103259000	USD
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	981000	USD
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	1125000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	119638000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-39812000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26934000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220128000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211727000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180316000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238661000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1988000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	mgnx	Fair Value Of Warrants Received FairValueOfWarrantsReceived	0	USD
	mgnx	Fair Value Of Warrants Received FairValueOfWarrantsReceived	6130000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16400000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	27700000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91786000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	34000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	91820000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2018	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2019Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.099
	us-gaap	Operating Lease Payments OperatingLeasePayments	3200000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17100000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	2701000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	618000	USD
	us-gaap	Sublease Income SubleaseIncome	471000	USD
	us-gaap	Lease Cost LeaseCost	2848000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3201000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5603000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5291000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5450000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5279000	USD
CY2019Q2	mgnx	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	4293000	USD
CY2019Q2	mgnx	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	10081000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39198000	USD
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11276000	USD
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	27922000	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4884000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4163000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8683000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7595000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5273964	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.23
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1796645	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.42
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	189428	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.25
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	119392	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.74
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6761789	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.52
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8883000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3722761	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8850000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6461922	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	22.46
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	8880000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.38
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2600000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3700000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	USD
CY2018Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	700000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6500000	USD
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6300000	USD
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	38700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D

Files In Submission

Name	View Source	Status
0001125345-19-000098-index-headers.html	Edgar Link	pending
0001125345-19-000098-index.html	Edgar Link	pending
0001125345-19-000098.txt	Edgar Link	pending
0001125345-19-000098-xbrl.zip	Edgar Link	pending
exhibit10-1servieramen.htm	Edgar Link	pending
exhibit10-2servieramen.htm	Edgar Link	pending
exhibit31-1q22019.htm	Edgar Link	pending
exhibit31-2q22019.htm	Edgar Link	pending
exhibit32-1q22019.htm	Edgar Link	pending
exhibit32-2q22019.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mgnx-20190630.htm	Edgar Link	pending
mgnx-20190630.xsd	Edgar Link	pending
mgnx-20190630_cal.xml	Edgar Link	unprocessable
mgnx-20190630_def.xml	Edgar Link	unprocessable
mgnx-20190630_htm.xml	Edgar Link	completed
mgnx-20190630_lab.xml	Edgar Link	unprocessable
mgnx-20190630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGNX
MACROGENICS INC Stock $mgnx

2019 Q3 Form 10-Q Financial Statement

#000112534519000098 Filed on July 31, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX MACROGENICS INC Stock $mgnx

2019 Q3 Form 10-Q Financial Statement

#000112534519000098 Filed on July 31, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX
MACROGENICS INC Stock $mgnx